Difference between revisions of "Aspirin and dipyridamole (Aggrenox)"
Jump to navigation
Jump to search
m |
Warner-admin (talk | contribs) m (Text replacement - "Category:Drug index" to "Category:Drugs") |
||
| Line 1: | Line 1: | ||
From the FDA label: A combination antiplatelet agent. Each hard gelatin capsule contains 200 mg of [[Dipyridamole (Persantine)|dipyridamole]] in an extended-release form and 25 mg of [[aspirin]], as an immediate-release sugar-coated tablet. | From the FDA label: A combination antiplatelet agent. Each hard gelatin capsule contains 200 mg of [[Dipyridamole (Persantine)|dipyridamole]] in an extended-release form and 25 mg of [[aspirin]], as an immediate-release sugar-coated tablet. | ||
| − | [[Category: | + | [[Category:Drugs]] |
[[Category:Oral medications]] | [[Category:Oral medications]] | ||
Revision as of 22:35, 13 June 2018
From the FDA label: A combination antiplatelet agent. Each hard gelatin capsule contains 200 mg of dipyridamole in an extended-release form and 25 mg of aspirin, as an immediate-release sugar-coated tablet.